Last reviewed · How we verify
NCT05948800: ISOtastic!
Impact of Nasal Isotonic Solution Irigation on Healthy Athletes' Nasal Flow and Nasal Obstruction Exercise Outcomes
NA trial testing Nasal irrigation with seawater isotonic solution in Nasal Obstruction in 50 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | University Hospital Sestre Milosrdnice |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 16 April 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Croatia |
Drugs / interventions tested
- Nasal irrigation with seawater isotonic solution
Conditions studied
- Nasal Obstruction — all drugs for Nasal Obstruction →
- Nasal Disease — all drugs for Nasal Disease →
Sponsor
University Hospital Sestre Milosrdnice
Who can join
Adults 18 to 40, any sex, with Nasal Obstruction or Nasal Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nasal patency is an important component of performing exercises because it helps in humidifying, heating and filtering the inhaled air. However, many athletes and exercisers experience difficulty breathing through their nose, which can affect their breathing and performance. Namely, during sports activities and greater physical effort, there is increased air flow, which causes significant dehydration and cooling of the mucous membrane of the upper respiratory system. This dehydration is associated with the release of inflammatory mediators, which can ultimately lead to narrowing of the airways (eg in athletes with asthma). However, in all athletes, regardless of whether they have asthma or not, damage to the airways can occur because during exercise, hyperpnea exposes the respiratory epithelium to increased physical forces and pressure, which leads to the risk of exfoliation of the previously dehydrated epithelial cells of the nose and even their complete separation. Repeated stretching and compression can negatively affect the functionality of the epithelium and, with repeated exposure and damage, lead to structural and functional changes. Rinsing the nose with a hypertonic or isotonic solution of seawater is a potential solution for nasal obstruction because after rinsing, the airflow through the nose improves and symptoms of obstruction are reduced. However, the effects of using nasal lavage solutions along with exercise in elite athletes are not yet known. The potential synergy of exercise and isotonic seawater solution as a nasal spray on airflow and the subjective impression of nasal patency in healthy individuals has not been sufficiently investigated5. Research question What is the effect of an isotonic seawater solution applied as a nasal spray on nasal airflow and the subjective impression of nasal obstruction in healthy athletes? Hypothesis An isotonic seawater solution applied as a nasal spray will improve nasal airflow and the subjective impression of nasal obstruction in healthy athletes.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Comparing Nasal Patency Outcomes in Patients Undergoing Septoplasty with Radiofrequency Turbinate Reduction, Turbinectomy, or Valvuloplasty: A Prospective Cohort Study.
Tomljenović D, Grgurić L, Knežević M, Svetina L, et al · · 2025 · PMID 41011047 · DOI 10.3390/medicina61091656 -
The Impact of Isotonic Seawater on Subjective and Objective Nose Patency in Athletes: A Randomized Controlled Trial.
Košec A, Vlahović T, Šilović B, Rakić M, et al · · 2025 · PMID 40283574 · DOI 10.3390/jcm14082742
Verify or expand the search:
- PubMed search for NCT05948800
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nasal Obstruction
Currently open trials in the same condition.
- NCT06580210 — Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Labora · recruiting
- NCT06830109 — Nasal Obstruction With Oxymetazoline and Corticosteroids · Phase 2 · recruiting
- NCT06670261 — Diagnosis of Respiratory Disorders by the Numerical Modeling. · recruiting
- NCT05494346 — Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patien · NA · recruiting
- NCT05920330 — Nasal Obstruction and Olfactory Losses · NA · recruiting
Other University Hospital Sestre Milosrdnice trials
Trials by the same sponsor.
- NCT07127848 — Investingation on Outcomes After Combining Septoplasty With Additional Procedures. · NA · enrolling by invitation
- NCT06384469 — The Impact of Rhinoplasty Approach and Used Autologous Cartilage Grafts on the Nasal Skin-soft Tissue Envelope Metabolis · not yet recruiting
- NCT05840406 — Effect of a Transversus Abdominis Plane Block on Wound Healing, Stress, and Immune Response After a Cesarean Delivery · NA · completed
- NCT06243536 — The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients · Phase 4 · unknown
- NCT05938985 — Croatian Version of the Ocular Surface Disease Index Questionnaire (OSDI) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05948800 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Sestre Milosrdnice
- Last refreshed: 17 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05948800.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing